Supernus Pharmaceuticals, Inc. (SUPN)
46.10
+0.68
(+1.50%)
USD |
NASDAQ |
Dec 10, 16:00
46.10
0.00 (0.00%)
After-Hours: 20:00
Supernus Pharmaceuticals EPS Diluted (Quarterly): -0.7978 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biogen, Inc. | 3.171 |
| BridgeBio Pharma, Inc. | -0.9525 |
| CorMedix, Inc. | 1.259 |
| Assembly Biosciences, Inc. | -0.7249 |
| Viking Therapeutics, Inc. | -0.8083 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -45.12M |
| Revenue (Quarterly) | 192.10M |
| Total Expenses (Quarterly) | 237.22M |
| Enterprise Value | 2.365B |
| Gross Profit Margin (Quarterly) | 77.20% |
| Profit Margin (Quarterly) | -23.49% |
| Earnings Yield | -0.74% |
| Normalized Earnings Yield | -0.6291 |